Wei et al. found a strong correlation between ER promoter and BRCA1 promoter methylation, suggesting a higher frequency of BRCA1 methylation in HR-negative breast cancers (no information was available on the HER2 status of these tumours) [43]. This evidence concerns the gene BRCA1 and breast carcinoma.